Safety and efficacy assessment of low-power holmium laser enucleation of the prostate

Abstract

Objective To assess the safety and efficacy of low-power holmium laser enucleation of the prostate (LP-HoLEP) for the treatment of benign prostate hyperplasia(BPH). Methods From July 2016 to June 2017, a total of 120 BPH patients in our hospital underwent LP-HoLEP(n=60) or TURP(n=60). The removal weight of proliferation, operation time, postoperative bladder irrigation time, hospital stay, postoperative maximum urinary flow rate Qmax, residual urine volume (RUV), IPSS and QOL were compared between two groups. Results All patients underwent successful HoLEP with the low-power setting. Compared with TURP groups, patients who underwent LP-HoLEP had more removal weight of proliferation, less operation time, less urinary tract infection occurrence rate, less postoperative bladder irrigation time and less hospital stay. These differences above were statistically significant(P 0.05). Conclusions LP-HoLEP is a safe and effective procedure for the treatment of BPH. Compared with HP-HPLEP, it is cost-effetive and worthy of clinical promotion. Key words: Prostatic Hyperplasia; Lasers, Solid-State; Prostatectomy